Inovalon Holdings joins Nasdaq

(Nasdaq:INOV)

Nasdaq (Nasdaq:NDAQ) announced that trading of Inovalon Holdings, Inc. (Nasdaq:INOV) a leading technology provider of advanced cloud-based data analytics and data-driven intervention platforms to the healthcare industry, commenced on The Nasdaq Stock Market on February 12, 2015.

In a statement the company said “Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and improvement in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. Their powerful platforms drive high-value impact, improving quality and economics for health plans, hospitals, physicians, patients, pharmaceutical companies, and researchers.

“The value they deliver to their clients is achieved by turning data into insights and those insights into action. During 2014, this value was provided to more than 100 clients, representing approximately 200 patient populations, through analytics informed by Inovalon’s proprietary data and insights on more than 754,000 physicians, 248,000 clinical facilities, and 120 million unique patients”.

“Inovalon uses advanced cloud –based technology solutions to provide meaningful improvement to healthcare organizations and patients nationwide,” said Nelson Griggs, Executive Vice President, Listing Services at Nasdaq. “We are excited to welcome Inovalon to the family of innovative technology companies that call Nasdaq home and we look forward to their continued growth and success in the future.”

By listing with Nasdaq, Inovalon joins many of the world’s largest and most revolutionary technology companies. Nasdaq is the exchange of choice to over 72 percent of technology companies listed in the U.S. markets.

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Plc. ADVFN Plc does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.

Comments are closed

WHAT IS ADVFN?

ADVFN covers all things stock market.

From the news and opinion pieces on pages like this to share discussion forums, charting tools, financials, live share prices and Level 2, order book data

If you trade or invest ADVFN has the tools you need to make the right decisions.

• 

  101 Ways to Pick Stock Market Winners

  You need the number one bestselling investment guide, the definitive text for day traders, investors and stock pickers.

• 

  The Death of Wealth

  Dissecting the global economy and the financial markets, the book lays out the evidence for the next economic game changer: the Death of Wealth.

• 

  Jagdip Cheema

• 

  Anthony Wintle

• 

  Glenmore Investments

• 

  Envion